Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
83.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (2)
✓ EMA GMP (2)
✓ MHRA GMP (4)
Quick Facts: Minaris Advanced Therapies
- Signal Score
- 83.5/100 (as of 2026-04-02)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
- Modalities
- CAR-T, Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates2 on record
MHRA GMP Certificates4 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Altaris Capital Partners
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Altaris Capital Partners
Financial assessment: 68.0/100
Capacity
70.0
Multi-site operations (4 manufacturing sites)
Sites: Philadelphia, PA, Allendale, NJ, Yokohama, Japan, Munich, Germany
Source: SEC EDGAR, press monitoring, company profiles
4 manufacturing sites
StatusLimited
Multi-site operations (4 manufacturing sites)
Sites: Philadelphia, PA, Allendale, NJ, Yokohama, Japan, Munich, Germany
Recent Press2 articles
Multi-site operations (4 manufacturing sites)
EMA GMP Compliance 2 certificates
2025-07
2024-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BY_04_GMP_2026_0001 | MINARIS Regenerative Medicine GmbH | Germany | 2025-07-30 | COMPLIANT |
| DE_BY_04_GMP_2026_0002 | MINARIS Regenerative Medicine GmbH | Germany | 2024-02-08 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
MHRA GMP Compliance 4 certificates
2017-03
2009-04
2009-04
2009-04
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK GMP 35210 Insp GMP 35210/978451-0004[H] | WUXI APPTEC INCORPORATED | 30066 | 2017-03-02 | COMPLIANT |
| UK GMP 35210 Insp GMP 35210/935445-0001 [H] | WUXI APPTEC INCORPORATED | 19112 | 2009-04-30 | COMPLIANT |
| UK GMP 35210 Insp GMP 35210/935445-0001 [V] | WUXI APPTEC INCORPORATED | 19112 | 2009-04-30 | COMPLIANT |
| UK GMP 35210 Insp GMP 35210/940604-0001[H] | WUXI APPTEC INCORPORATED | 55120 | 2009-04-27 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Apr 05, 2026
Recent News 2 articles
Minaris Advanced Therapies launches new manufacturing facility in Munich - MSN
Minaris Advanced Therapies launches new manufacturing facility in Munich MSN
Minaris Unveils GMP-Grade NGS to Redefine Viral Safety Testing for Biologics and Advanced Therapies - BioBuzz
Minaris Unveils GMP-Grade NGS to Redefine Viral Safety Testing for Biologics and Advanced Therapies news.biobuzz.io
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.7
CAR-T, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.9
CAR-T, Cell Therapy, AAV
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 80.2
CAR-T, Cell Therapy, AAV, Lentiviral
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.2
CAR-T, Cell Therapy, iPSC, Gene Editing